Tyme Technologies Inc
NASDAQ:TYME
Tyme Technologies Inc
Common Stock
Tyme Technologies Inc
Common Stock Peer Comparison
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tyme Technologies Inc
NASDAQ:TYME
|
Common Stock
$17.2k
|
CAGR 3-Years
20%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Common Stock
$18m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Stock
$1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Stock
$33.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Stock
$2.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
3%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Stock
$101.8k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Tyme Technologies Inc's Common Stock?
Common Stock
17.2k
USD
Based on the financial report for Jun 30, 2022, Tyme Technologies Inc's Common Stock amounts to 17.2k USD.
What is Tyme Technologies Inc's Common Stock growth rate?
Common Stock CAGR 5Y
11%
Over the last year, the Common Stock growth was 0%. The average annual Common Stock growth rates for Tyme Technologies Inc have been 20% over the past three years , 11% over the past five years .